Literature DB >> 20884418

Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential "thromborestenosis" phenomenon.

Yuji Oikawa1, Junji Yajima, Marco A Costa, Shunsuke Matsuno, Masafumi Akabane, Ryuichi Funada, Toshiro Inaba, Yuya Nakagawa, Michinari Nakamura, Kazuyuki Nagashima, Hajime Kirigaya, Ken Ogasawara, Hitoshi Sawada, Tadanori Aizawa.   

Abstract

AIMS: Histopathology of DES restenosis remains unclear. The purpose is to examine restenotic tissue characteristics after sirolimus-eluting stent (SES) and comparing with that after bare-metal stent (BMS). METHODS AND
RESULTS: Intravascular ultrasound (IVUS), coronary angioscopy (CAS), and directional coronary atherectomy were performed simultaneously in 21 patients who presented restenosis after SES (n=13) and BMS (n=8). Mean time of restenosis was 10.8 months in the SES versus 7.5 months in the BMS. Typical "black hole'', echolucent appearance by IVUS was observed in one SES case, and corresponded to a fibrin rich tissue by histology which appeared translucent tissue by CAS. CAS did not reveal red thrombus, but showed white thrombus in six SES versus two BMS (46.2% vs. 25.0%, p=0.597). Histology demonstrated various patterns after SES including thrombus, fibrin, inflammatory infiltrate, and collagen-matrix rich tissue, while thrombus component was not detected in BMS. Thrombus and fibrin deposition detected by either CAS or histopathology were observed more frequently in SES than in BMS group (92.3% vs. 25.0%, p=0.007).
CONCLUSIONS: Restenosis after SES and BMS have different clinical and histological patterns. SES restenosis may be frequently associated with thrombus component.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20884418     DOI: 10.4244/EIJV6I3A63

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  9 in total

1.  Evaluation of in-stent neointimal tissue components using integrated backscatter intravascular ultrasound: comparison of drug-eluting stents and bare-metal stents.

Authors:  Yoshitaka Muraoka; Shinjo Sonoda; Kuninobu Kashiyama; Fumihiko Kamezaki; Yuki Tsuda; Masaru Araki; Masahiro Okazaki; Yutaka Otsuji
Journal:  Int J Cardiovasc Imaging       Date:  2011-12-18       Impact factor: 2.357

2.  Coronary angioscopic imaging of in-stent restenosis after biolimus-eluting coronary stent implantation.

Authors:  Shigenori Ito; Tomoaki Saeki
Journal:  J Cardiol Cases       Date:  2015-08-11

3.  Lower on-treatment platelet reactivity during everolimus-eluting stent implantation contributes to the resolution of post-procedural intra-stent thrombus: serial OCT observation in the PRASFIT-Elective study.

Authors:  Akihide Konishi; Masamichi Iwasaki; Toshiro Shinke; Hiromasa Otake; Masayuki Nakagawa; Hirotoshi Hariki; Tsuyoshi Osue; Takumi Inoue; Yu Taniguchi; Ryo Nishio; Hiroto Kinutani; Noritoshi Hiranuma; Masaru Kuroda; Ken-Ichi Hirata; Shigeru Saito; Masato Nakamura; Junya Shite; Takashi Akasaka
Journal:  Heart Vessels       Date:  2018-07-02       Impact factor: 2.037

4.  Black hole restenosis after drug-eluting stent implantation for in-stent restenosis: potential mechanism and optimal strategy.

Authors:  Yoritaka Otsuka; Takashi Murata; Michiaki Kono; Hiroki Imoto; Taku Koyama; Keita Nakamura; Sunao Kadama; Hiroo Noguchi; Taro Saito
Journal:  Heart Vessels       Date:  2014-06-07       Impact factor: 2.037

5.  Impact of cytochrome P450 2C19*2 polymorphism on intra-stent thrombus assessed by follow-up optical coherence tomography in Chinese patients receiving clopidogrel.

Authors:  Shan Li; Yang Shi; Haijun Wang; Wei Zhang; Jianfeng Liu
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

6.  Thrombus-related focal in-stent restenosis after everolimus-eluting stent implantation.

Authors:  Tomohiro Hayashi; Jun-ichi Kotani; Hatsue Ishibashi-Ueda; Satoshi Yasuda
Journal:  Heart Vessels       Date:  2013-04-18       Impact factor: 2.037

7.  CYP2C192 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls.

Authors:  Jenny Ruedlinger; Yalena Prado; Tomás Zambrano; Nicolás Saavedra; Braulio Bobadilla; Marcelo Potthoff; Luis Pérez; Fernando Lanas; Luis A Salazar
Journal:  Biomed Res Int       Date:  2017-07-13       Impact factor: 3.411

8.  In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario.

Authors:  Ganesh Paramasivam; Tom Devasia; Shabeer Ubaid; Ashwitha Shetty; Krishnananda Nayak; Umesh Pai; Mugula Sudhakar Rao
Journal:  Egypt Heart J       Date:  2019-11-27

9.  The impact of acute coronary syndrome on late drug-eluting stents restenosis: Insights from optical coherence tomography.

Authors:  Sijing Wu; Wei Liu; Yonghe Guo; Yaping Zeng; Zhiming Zhou; Yingxin Zhao; Yuyang Liu; Dongmei Shi; Zhijian Wang; Hailong Ge; Jianlong Wang; Peng Jin; Yujie Zhou
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.